C D Spence, J P Coghlan, D A Denton, C E Gomez-Sanchez, E H Mills, M A Nelson, J A Whitworth, B A Scoggins
Index: Clin. Exp. Hypertens. A. 6(9) , 1591-600, (1984)
Full Text: HTML
The present study examines the blood pressure and metabolic effects of 5 day infusions of 19-nor-deoxycorticosterone (19-nor-DOC) and 19- nor-progesterone (19-nor-PROG) in the intact conscious sheep. Both these steroids raise blood pressure in the rat. 19-nor-DOC (5 mg/d) produced a significant increase in mean arterial pressure (MAP) of 17 mmHg on day 5 (p less than 0.001), associated with 'mineralocorticoid' effects hypokalaemia, hypernatraemia and an initial urinary sodium retention. In contrast 19-nor-PROG (5 mg/d and 50 mg/d) had no effect on MAP and displayed no 'mineralocorticoid' activity.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
19-Norpregn-4-ene-3,20-dione
CAS:472-54-8 |
C20H28O2 |
|
Structure-activity relationships of synthetic progestins in ...
2008-05-01 [J. Steroid Biochem. Mol. Biol. 110(1-2) , 39-47, (2008)] |
|
The pharmacology of nomegestrol acetate.
2012-04-01 [Maturitas 71(4) , 345-53, (2012)] |
|
Interaction of new 19 nor progesterone derivatives with prog...
1986-01-01 [J. Pharmacol. 17(4) , 699-706, (1986)] |
|
19-Nor-corticosteroids in experimental and human hypertensio...
1982-01-01 [Clin. Exp. Hypertens. A. 4(9-10) , 1851-67, (1982)] |
|
Lack of estrogenic potential of progesterone- or 19-nor-prog...
1995-10-01 [J. Steroid Biochem. Mol. Biol. 55(1) , 77-84, (1995)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
